Published in Psychosom Med on May 31, 1990
Association between maternal anxiety in pregnancy and increased uterine artery resistance index: cohort based study. BMJ (1999) 2.54
Impact of maternal stress, depression and anxiety on fetal neurobehavioral development. Clin Obstet Gynecol (2009) 1.35
The effects of maternal anxiety prior to amniocentesis on uterine and fetal umbilical blood flow. J Turk Ger Gynecol Assoc (2009) 0.82
Biomarkers of a five-domain translational substrate for schizophrenia and schizoaffective psychosis. Biomark Res (2015) 0.78
Biomarker Case-Detection and Prediction with Potential for Functional Psychosis Screening: Development and Validation of a Model Related to Biochemistry, Sensory Neural Timing and End Organ Performance. Front Psychiatry (2016) 0.76
The dawn of Darwinian medicine. Q Rev Biol (1991) 2.35
Pentagastrin infusions in patients with panic disorder. I. Symptoms and cardiovascular responses. Biol Psychiatry (1994) 1.53
Marital quality and psychological adjustment to widowhood among older adults: a longitudinal analysis. J Gerontol B Psychol Sci Soc Sci (2000) 1.51
Childhood adversity and vulnerability to mood and anxiety disorders. Depress Anxiety (1997) 1.27
The effects of menstrual phase and nicotine abstinence on nicotine intake and on biochemical and subjective measures in women smokers: a preliminary report. Psychoneuroendocrinology (1992) 1.18
Physician-scientists at risk. Science (1999) 1.16
Persistent respiratory irregularity in patients with panic disorder. Biol Psychiatry (2001) 1.11
Pretreatment nausea in cancer chemotherapy: a conditioned response? Psychosom Med (1980) 1.08
Medial frontal cortex involvement in PTSD symptoms: a SPECT study. J Psychiatr Res (1999) 1.04
Adrenergic function in patients with panic anxiety. Arch Gen Psychiatry (1984) 1.01
Evolution and the origins of disease. Sci Am (1998) 1.00
Respiratory psychophysiology and anxiety: cognitive intervention in the doxapram model of panic. Psychosom Med (1996) 0.96
Influence of exercise on anxiety level in patients with anxiety disorders. Psychosomatics (1986) 0.94
Hypothalamic-pituitary-adrenocortical activity in patients with diabetes mellitus. Arch Gen Psychiatry (1984) 0.93
Ages of onset of DSM-III anxiety disorders. Compr Psychiatry (1985) 0.91
Effect of alcohol on social phobic anxiety. Am J Psychiatry (1999) 0.90
Hypercortisolism in diabetes mellitus. Diabetes Care (1988) 0.89
Blunted growth hormone response to clonidine in patients with generalized anxiety disorder. Arch Gen Psychiatry (1991) 0.88
Cholecystokinin-4 and panic. Arch Gen Psychiatry (1990) 0.86
Anxiety and caffeine consumption in people with anxiety disorders. Psychiatry Res (1985) 0.86
Pentagastrin infusions in patients with panic disorder. II. Neuroendocrinology. Biol Psychiatry (1994) 0.85
Alcohol abuse among clinically anxious patients. Behav Res Ther (1986) 0.84
Anxiogenic effects of caffeine on panic and depressed patients. Am J Psychiatry (1988) 0.83
Endocrine and cardiovascular responses during phobic anxiety. Psychosom Med (1985) 0.83
A comparison of panic disorder and agoraphobia with panic attacks. Compr Psychiatry (1985) 0.83
Group behavioral therapy of obsessive-compulsive disorder: seven vs. twelve-week outcomes. Depress Anxiety (2001) 0.82
Alpha 2-adrenoreceptor status in obsessive-compulsive disorder. Biol Psychiatry (1990) 0.82
Defense mechanism changes in successfully treated patients with obsessive-compulsive disorder. Am J Psychiatry (1998) 0.82
Anxiety and cardiovascular reactivity in the Tecumseh population. J Hypertens (1998) 0.82
Intravenous yohimbine. Selective enhancer of norepinephrine and cortisol secretion and systolic blood pressure in humans. Clin Neuropharmacol (1989) 0.81
Neuroendocrine responses to laboratory panic: cognitive intervention in the doxapram model. Psychoneuroendocrinology (1996) 0.81
A standardized behavioral group treatment program for obsessive-compulsive disorder: preliminary outcomes. Behav Res Ther (1991) 0.80
Systemic hormonal and physiological abnormalities in anxiety disorders. Psychoneuroendocrinology (1988) 0.80
Circadian fluctuation of plasma epinephrine in supine humans. Psychoneuroendocrinology (1987) 0.80
Urinary catecholamines and mitral valve prolapse in panic-anxiety patients. Psychiatry Res (1985) 0.80
The differential diagnosis of anxiety. Psychiatric and medical disorders. Psychiatr Clin North Am (1985) 0.78
Anxiety induced by flooding therapy for phobias does not elicit prolactin secretory response. Psychosom Med (1980) 0.78
Case histories and shorter communications. Agoraphobia: a test of the separation anxiety hypothesis. Behav Res Ther (1985) 0.78
Hypothalamic-pituitary-adrenal axis activity in panic disorder: effects of alprazolam on 24 h secretion of adrenocorticotropin and cortisol. J Psychiatr Res (1996) 0.77
A behavioral and pharmacological analysis of some discriminable properties of d-LSD in rats. Psychopharmacologia (1973) 0.77
Free 3-methoxy-4-hydroxyphenylglycol determined in plasma by liquid chromatography with coulometric detection. Clin Chem (1989) 0.77
Psychopharmacology. Psychosom Med (1999) 0.77
Circadian symptom fluctuations in people with anxiety disorders. J Affect Disord (1987) 0.77
The function of consciousness. Trends Neurosci (1998) 0.77
Frequency of panic disorder in summer. Am J Psychiatry (1989) 0.77
An evolutionary perspective on psychiatry. Compr Psychiatry (1985) 0.77
Conditioned suppression of bar-pressing behavior by stimuli associated with drugs. J Exp Anal Behav (1972) 0.76
Treatment of panic-like attacks with a long-acting analogue of somatostatin. J Clin Psychopharmacol (1990) 0.76
Anxiety in patients with pheochromocytomas. Arch Intern Med (1985) 0.76
Platelet alpha 2-adrenoreceptors, catecholamines, hemodynamic variables, and anxiety in panic patients and their asymptomatic relatives. Psychosom Med (1996) 0.76
Evolutionary biology: a basic science for psychiatry? Acta Psychiatr Scand (1992) 0.76
Drug-induced conditioned suppression: specificity due to drug employed as UCS. Pharmacol Biochem Behav (1976) 0.76
Serial dexamethasone suppression tests in depressed patients treated only with electroconvulsive therapy. J Affect Disord (1988) 0.75
Pseudohallucinations in cancer chemotherapy patients. Am J Psychiatry (1983) 0.75
Pilocarpine for anticholinergic adverse effects associated with desipramine treatment. Am J Psychiatry (1996) 0.75
Obsessive-compulsive disorder and the DST. Psychiatry Res (1986) 0.75
Psychobiology of anxiety and anxiety disorders. Psychiatr Clin North Am (1985) 0.75
Simple phobia: evidence for heterogeneity. Psychiatry Res (1989) 0.75
Safe use of haloperidol in a patient with cardiac dysrhythmia. Am J Psychiatry (1978) 0.75
Phobic anxiety does not affect plasma levels of thyroid stimulating hormone in man. Psychoneuroendocrinology (1982) 0.75
The dexamethasone suppression test in panic disorder and agoraphobia. Am J Psychiatry (1982) 0.75
Anxiety and sexual arousal. Am J Psychiatry (1985) 0.75
Symptom profiles of patients with DSM-III anxiety disorders. Am J Psychiatry (1986) 0.75
Anxiety, type A behavior, and cardiovascular disease. Int J Psychiatry Med (1986) 0.75
Letter: Children's behavior under stimulant drugs. N Engl J Med (1973) 0.75
Panic disorder: a test of the separation anxiety hypothesis. Behav Res Ther (1986) 0.75
Differences between smokers and never-smokers in sensitivity to nicotine: a preliminary report. Addiction (1993) 0.75
Lithium carbonate treatment of mania associated with Klinefelter's syndrome. JAMA (1980) 0.75
Treatment of pavor nocturnus with alprazolam. J Clin Psychiatry (1985) 0.75
Endocrine, cardiovascular, and behavioral responses to clonidine in patients with panic disorder. Biol Psychiatry (1992) 0.75
Comparison of acute and chronic lithium treatment on 3H-norepinephrine uptake by rat brain slices. Psychopharmacology (Berl) (1980) 0.75
Chronic caffeine consumption and the dexamethasone suppression test in depression. Psychiatry Res (1988) 0.75
Effects of ACTH and prednisone on mood: incidence and time of onset. Int J Psychiatry Med (1986) 0.75
Stimulation of corticotropin release by pentagastrin in normal subjects and patients with panic disorder. Biol Psychiatry (1991) 0.75
An anticholinergic toxicity reaction to chlorpromazine activated by psychological stress. J Nerv Ment Dis (1979) 0.75
Behavior therapy of phobias: predictors of outcome. Psychiatry Res (1986) 0.75
Diagnostic and gender differences in the expressed fears of anxious patients. J Behav Ther Exp Psychiatry (1985) 0.75
Clomipramine treatment of possible atypical obsessive-compulsive disorder. J Clin Psychopharmacol (1990) 0.75
How antipanic drugs might work. Am J Psychiatry (1986) 0.75
The daily distribution of panic attacks. Compr Psychiatry (1988) 0.75
Platelet alpha 2-adrenergic receptor binding and plasma catecholamines. Before and during imipramine treatment in patients with panic anxiety. Arch Gen Psychiatry (1984) 0.75
Aerobic physical training and alterations in pressor response during norepinephrine infusion: a controlled single-subject experiment. Int J Sports Med (1990) 0.75
Clinical response to clonidine and imipramine, and platelet alpha 2-adrenoreceptors in a case of agoraphobia with panic attacks. Biol Psychiatry (1982) 0.75